Journal of Hypertension
 2000
DOI: 10.1097/00004872-200006001-00315
|View full text |Cite
|
Sign up to set email alerts
|

Omapatrilat in Persons With Enhanced Risk of Atherosclerotic Events

Pierre François Plouin
1
,
G. Mancia2,
Stuart M. Cobbe3
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0
1

Year Published

2001
2001
2001
2001

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
0
0
1
Order By: Relevance
“…Mit OPERA (Omapatrilat in Persons with Enhanced Risk of Atherosclerotic Events) ist bereits eine weltweite, randomisierte, doppelblinde, multizentrische Morbiditäts-und Mortalitätsstudie initiiert worden, in der an etwa 12600 Patienten mit isolierter systolischer Hypertonie der Einfluss von Omapatrilat auf die kardiovaskuläre Morbidität und Mortalität untersucht wird. Der Untersuchungszeitraum ist auf 5 Jahre angelegt (40).…”
Section: Klinische Studienunclassified

Vasopeptidase inhibition, a new pharmacological principle in the treatment of hypertension and heart failure

Kolloch
1
,
Offers2
2001
Dtsch med Wochenschr
0
0
0
0
View full textAdd to dashboardCite
“…Mit OPERA (Omapatrilat in Persons with Enhanced Risk of Atherosclerotic Events) ist bereits eine weltweite, randomisierte, doppelblinde, multizentrische Morbiditäts-und Mortalitätsstudie initiiert worden, in der an etwa 12600 Patienten mit isolierter systolischer Hypertonie der Einfluss von Omapatrilat auf die kardiovaskuläre Morbidität und Mortalität untersucht wird. Der Untersuchungszeitraum ist auf 5 Jahre angelegt (40).…”
Section: Klinische Studienunclassified

Vasopeptidase inhibition, a new pharmacological principle in the treatment of hypertension and heart failure

Kolloch
1
,
Offers2
2001
Dtsch med Wochenschr
0
0
0
0
View full textAdd to dashboardCite

Vasopeptidaseinhibition

Kolloch1,
Offers2
2001
Der Internist
0
0
0
0
View full textAdd to dashboardCite
scite logo

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Product
Browser ExtensionAssistant by sciteCitation Statement SearchReference CheckVisualizationsDashboardsExplore JournalsExplore OrganizationsExplore FundersEmbedding BadgeEmbedding Citation SearchPricing
Resources
BlogHelp & FAQAccessibility StatementAPI TermsFor Universities & GovernmentsFor ResearchersFor PublishersFor Corporate, Pharma & EnterpriseAuthor MarketingBecome an AffiliateGet an organization trial or quotescite Data & Services
About
News & PressCareersRead our PaperCoverage

BlogTerms and ConditionsAPI TermsPrivacy PolicyContactCookie PreferencesDo Not Sell or Share My Personal Information

Copyright © 2024 scite LLC. All rights reserved.

Made with 💙 for researchers

Part of the Research Solutions Family.